Lenstec SBL-3 multifocal intraocular lens for cataract surgery approved by FDA for sale in the US
Thursday, July 28, 2022
(0 Comments)
Lenstec SBL-3 multifocal intraocular lens for cataract surgery approved by FDA for sale in the US
Lenstec Inc. has announced that its SBL-3 IOL has been approved by the FDA.
ST. PETERSBURG, Fla., July 28, 2022
/PRNewswire/ -- The Lenstec SBL-3 IOL (Segmented Bifocal Lens) is a
next-generation asymmetric multifocal refractive IOL which provides
patients with near, intermediate and distance vision. Its patented
design allows for improved contrast sensitivity and minimized halo and
glare (dysphotopsias) commonly associated with other traditional
'concentric ring' multifocal IOLs.
Next generation multifocal intraocular lens FDA approved for sale in the US. The
segmented optic design is the first of its kind in the US. Lenstec's
patented four-point fixation and design allow surgeons confidence in the
IOLs effective lens position within the capsule. Its availability in
0.25 diopter power increments, along with the tightest industry
tolerances (+/- 0.11 diopters from labeled power), assists surgeons in
achieving the best refractive outcomes possible.
James Loden, MD (Nashville, TN),
a principal investigator in the FDA trial, notes, "SBL-3 lens patients
reported high quality distance and near vision, without the headache of
severe dysphotopsia issues, and we had no complaints with computer
vision."
Sebastian Heersink, MD (Dothan, AL),
another FDA trial principal investigator, stated, "in my own experience
with the SBL-3, I have been very impressed with the quality and range
of functional vision patients obtained, as well as their overall
happiness. It performs well in low lighting and patients report
excellent night driving. It's a great lens that I wouldn't hesitate to
have implanted in my own eyes."
About Lenstec Lenstec
is a leading designer and manufacturer of intraocular Lenses (IOLs) to
treat patients with a range of vision disorders. Founded in 1992, the
company is dedicated to advancing possibilities for ophthalmic
professionals and their patients worldwide.
More information about the SBL-3 and Lenstec's line of Precision Series IOLs is available at www.lenstec.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lenstec-sbl-3-multifocal-intraocular-lens-for-cataract-surgery-approved-by-fda-for-sale-in-the-us-301595737.html
SOURCE Lenstec Inc
|